Relapsed/ Refractory MDS
Showing 1 - 25 of >10,000
AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)
Not yet recruiting
- AML/MDS
- +2 more
- Danvatirsen
- Danvatirsen + Venetoclax
- (no location specified)
Aug 14, 2023
AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)
Recruiting
- AML
- MDS
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital
Nov 30, 2023
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
AML, MDS Trial in Tianjin (XZB-0004)
Not yet recruiting
- AML
- MDS
-
Tianjin, Tianjin, ChinaHematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- 6MW3211 injection with Intravenous Infusion
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 2, 2022
Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123
Recruiting
- Leukemia
- +3 more
- MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
-
Amsterdam, Netherlands
- +4 more
Jan 4, 2023
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)
Withdrawn
- Relapsed Acute Myeloid Leukemia
- +2 more
- Cytokine-induced memory-like NK cells
- +4 more
- (no location specified)
Feb 23, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome
- ASP7517
-
Duarte, California
- +15 more
Jan 19, 2023
AML, Adult Recurrent, MDS Trial in Durham (DVX201)
Recruiting
- AML, Adult Recurrent
- MDS
- DVX201
-
Durham, North CarolinaDuke University Hospital
Feb 11, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
MDS, Acute Myeloid Leukemia Trial in France (BST-236)
Recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Amiens, France
- +16 more
Jan 2, 2023
Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)
Recruiting
- Leukemia, Acute
- +3 more
- Palliative Care Visits
-
Charlottesville, VirginiaUniversity of Virginia
Apr 28, 2022
Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-BĂ©nite (ABD-3001)
Active, not recruiting
- Acute Myeloid Leukemia, Adult
- Myelodysplastic Syndromes
-
Marseille, France
- +2 more
Jan 19, 2023
Refractory Acute Myeloid Leukemia, Relapsed Acute Myelomonocytic Leukemia, MDS Trial in Cleveland (CPX-351)
Recruiting
- Refractory Acute Myeloid Leukemia
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Mar 15, 2022
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Leukemia, Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Tianjin (MAX-40279-01)
Recruiting
- Leukemia
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 29, 2021
Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Chronic Myelomonocytic Leukemia Trial
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2022